Evidence map›Paper›PMID 29696831›Full record

ReviewAdvanced healthcare materials2018

In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease.

Alastair Khodabukus, Neel Prabhu, Jason Wang, Nenad Bursac

Open access · bronzeAbstract readReview
In one paragraph

Review in Advanced healthcare materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Isolation and Culture of Primary Myoblasts from Humans and Mice.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alastair KhodabukusDepartment of Biomedical Engineering, Duke University, 101 Science Drive, FCIEMAS 1427, Durham, NC, 27708-90281, USA.
Neel PrabhuDepartment of Biomedical Engineering, Duke University, 101 Science Drive, FCIEMAS 1427, Durham, NC, 27708-90281, USA.
Jason WangDepartment of Biomedical Engineering, Duke University, 101 Science Drive, FCIEMAS 1427, Durham, NC, 27708-90281, USA.
Nenad BursacDepartment of Biomedical Engineering, Duke University, 101 Science Drive, FCIEMAS 1427, Durham, NC, 27708-90281, USA.ORCID 0000-0003-2218-7083
Duke University · US

Funding

Interaction of Subchondral Bone and Articular Cartilage System with Skeletal MuscleUH3TR000505 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2014 to 2016
$3.6M
Systemic Inflammation in Microphysiological Models of Muscle and Vascular DiseaseUG3TR002142 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2017 to 2018
$2.1M
Circulatory system and integrated muscle tissue for drug and tissue toxicityUH2TR000505 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2012 to 2013
$2.1M
Muscle-macrophage constructs for skeletal muscle repairR01AR070543 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD · 2016 to 2020
$1.9M
Translational studies of GAA deficiency in bioengineered human muscleR01AR065873 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD, KOEBERL, DWIGHT D · 2013 to 2017
$1.8M
NCATS NIH HHS UG3 TR002142NCATS NIH HHS UH2 TR000505NCATS NIH HHS UH3 TR000505NIAMS NIH HHS R01 AR065873NIAMS NIH HHS R01 AR070543
6 · The paper itself

Abstract

Healthy skeletal muscle possesses the extraordinary ability to regenerate in response to small-scale injuries; however, this self-repair capacity becomes overwhelmed with aging, genetic myopathies, and large muscle loss. The failure of small animal models to accurately replicate human muscle disease, injury and to predict clinically-relevant drug responses has driven the development of high fidelity in vitro skeletal muscle models. Herein, the progress made and challenges ahead in engineering biomimetic human skeletal muscle tissues that can recapitulate muscle development, genetic diseases, regeneration, and drug response is discussed. Bioengineering approaches used to improve engineered muscle structure and function as well as the functionality of satellite cells to allow modeling muscle regeneration in vitro are also highlighted. Next, a historical overview on the generation of skeletal muscle cells and tissues from human pluripotent stem cells, and a discussion on the potential of these approaches to model and treat genetic diseases such as Duchenne muscular dystrophy, is provided. Finally, the need to integrate multiorgan microphysiological systems to generate improved drug discovery technologies with the potential to complement or supersede current preclinical animal models of muscle disease is described.

Indexed as

AnimalsBioengineeringHumansMuscle, SkeletalPluripotent Stem CellsSatellite Cells, Skeletal MuscleTissue Engineeringdisease modelinginduced pluripotent stem cellsskeletal musclemuscular dystrophytissue engineering

Identifiers

PMID29696831
PMCPMC6105407
OpenAlexW2801983475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.